- Home
- GGG vs ASND Comparison
GGG vs ASND Comparison
Compare GGG & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GGG | ASND |
|---|---|---|
| Founded | 1926 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 14.7B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GGG | ASND |
|---|---|---|
| Price | $86.92 | $245.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 16 |
| Target Price | $95.25 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 861.4K | 504.7K |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | ★ 9.22 | N/A |
| EPS | ★ 3.08 | N/A |
| Revenue | ★ $2,236,604,000.00 | N/A |
| Revenue This Year | $6.77 | $96.35 |
| Revenue Next Year | $4.86 | $44.91 |
| P/E Ratio | $28.18 | ★ N/A |
| Revenue Growth | ★ 5.83 | N/A |
| 52 Week Low | $77.19 | $151.11 |
| 52 Week High | $95.69 | $250.74 |
Technical Indicators
Market Signals| Indicator | GGG | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 61.14 |
| Support Level | $81.15 | $190.49 |
| Resistance Level | $88.15 | $249.67 |
| Average True Range (ATR) | 1.84 | 8.42 |
| MACD | 0.24 | 1.73 |
| Stochastic Oscillator | 59.83 | 85.60 |
Price Performance
Historical ComparisonAbout GGG Graco Inc.
Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2025.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.